CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-02-22 | STOLICK DAVID Chief Financial Officer | Sale | −100,000 | $0.36 | $36K | 150,000 |
| 2010-02-17 | STOLICK DAVID Chief Financial Officer | Sale | −2,000 | $0.36 | $720 | 250,000 |
| 2010-02-16 | STOLICK DAVID Chief Financial Officer | Sale | −3,000 | $0.36 | $1K | 392,000 |
| 2010-02-16 | STOLICK DAVID Chief Financial Officer | Sale | −140,000 | $0.36 | $50K | 252,000 |
| 2010-02-12 | STOLICK DAVID Chief Financial Officer | Sale | −5,000 | $0.36 | $2K | 395,000 |
| 2010-02-12 | STOLICK DAVID Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | +400,000 | 0 | ||
| 2009-06-29 | STOLICK DAVID Chief Financial Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2007-03-21 | STOLICK DAVID Chief Financial Officer | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2006-05-02 | STOLICK DAVID Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2006-02-06 | STOLICK DAVID Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −400,000 | 0 | ||
| 2006-02-06 | STOLICK DAVID Chief Financial Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2005-03-29 | STOLICK DAVID Chief Financial Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 |
Page 1 of 1 · 12 trades